Anavex Life Sciences Corp (AVXL)

[TrueTrades]

Did you research the trial design?

What we have now is anecdotal evidence from a small sample.

Adaptive Design Clinical Trials for Drugs and Biologics

Population Pharmacokinetics - Food and Drug Administration

A small sample is all that's needed and the evidence is far from anecdotal.

Just a general comment on the posts about the data presented so-far (I know your comment was off-cuff...just picked your post to reply to no need to bite-back!). Yes, anyone who believes a P3 could be skipped is delusional. But, it is important to realize that it is a combo therapy and measured against an already FDA-approved set of benchmarks. I suggest to all to research the FDA approval processes thoroughly (yes, it's worse than sec filings!), especially where new approval regulations and CNS diseases are concerned...then read-up on Dr Missling and his statements. Put the two together and you will understand the direction the company is taking without having to wait for news confirmation.

Better-yet, read the links in this post...they were chosen to encapsulate this exact idea.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116057463

Keep in mind that as great as 2-73 may be, some feel that 3-71 will be even better. So Anavex has a lot of options. For example, they could partner with big pharma for 2-73 very soon for Epilespy trial, and get a lot of upfront cash. And then a bundle more for phase 2B or 3 for Alzheimer's.
Then they can develop 3-71 and keep it entirely for themself.

YES! The pipeline is rich...a successful 2-73 will make it $$$GOLDEN$$$.

Very much at a pivot point for the company in the next year!
§AVXL